Iris Bincovich
Vermögen: 578 954 $ am 31.01.2026
Vermögen: 578 954 $ am 31.01.2026
Iris Or Gabi Bincovich is the founder of InnoCan Pharma Corp.
since 2018, holding the title of Chairman & Chief Executive Officer.
Former job at Pollogen Ltd. as Manager-Business Unit from 2012 to 2014.
Former job at Starlet Derma Ltd. as Vice President-Business Development from 2014 to 2015.
Former job at Kamedis as Vice President-Global Marketing & Sales from 2015 to 2017.
Education includes an undergraduate degree from Technion-Israel Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.07.2025 | 82.826 ( 1,84 % ) | 578 954 $ | 31.01.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOCAN PHARMA CORPORATION | Vorstandsvorsitzender | 31.05.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Kamedis
Kamedis Develops skin care products and sells through online store | Vertrieb & Marketing | 01.12.2017 |
Starlet Derma Ltd.
Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel marine extracted microinjection system for efficient Intra-dermal penetration | Corporate Officer/Principal | 01.09.2015 |
Pollogen Ltd.
Pollogen Ltd. Provides medical aesthetic devices | Corporate Officer/Principal | 01.01.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Pollogen Ltd.
Pollogen Ltd. Provides medical aesthetic devices | |
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Starlet Derma Ltd.
Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel marine extracted microinjection system for efficient Intra-dermal penetration | Health Technology |
Kamedis
Kamedis Develops skin care products and sells through online store | |
InnoCan Pharma Corp.
InnoCan Pharma Corp. Manufactures pharmaceuticals |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition